China NMPA Product Recall - Heparin-treated hydrophilic acrylic intraocular lenses
China NMPA product recall for Heparin-treated hydrophilic acrylic intraocular lenses by HexaVision SARL published July 31, 2018. Recall level: Level 3 Recall. HexaVision SARL, in conjunction with its agent Beijing Millennium Golden Sail Pharmaceutical Technol
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Heparin-treated hydrophilic acrylic intraocular lenses by HexaVision SARL published July 31, 2018. Recall level: Level 3 Recall. HexaVision SARL, in conjunction with its agent Beijing Millennium Golden Sail Pharmaceutical Technol
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
HexaVision SARLInspection Date
Unknown Date
Product Type
ID: 93556ce5-c0eb-48ab-8fc9-9cb9764fd902
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox